Literature DB >> 9883961

A physiological approach to surgical treatment of progressive early idiopathic scoliosis.

B Xiong1, J A Sevastik.   

Abstract

The results of previous clinical and experimental studies have provided accumulated evidence for the role of rib asymmetry in the pathogenesis of idiopathic scoliosis (IS). Moreover, it has been shown that scoliosis induced in rabbits can be corrected by elongation or growth stimulation of ribs on the side of the convexity. Taking these observations into consideration, a 7-year-old girl with right convex thoracolumbar IS was operated upon by 2-cm shortening of three concave ribs. The preoperative coronal Cobb angle was 46 degrees and the sagittal angle was 55 degrees. Twenty-seven months after the operation the curves were reduced to 21 degrees and 35 degrees, or by 54 and 36%, respectively. It is concluded that new, easy to perform and harmless interventions on the ribs may have vast implications for the overall treatment of young patients with early progressive, thoracic, IS.

Entities:  

Mesh:

Year:  1998        PMID: 9883961      PMCID: PMC3611305          DOI: 10.1007/s005860050115

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  3 in total

1.  Biomechanical modelling of growth modulation following rib shortening or lengthening in adolescent idiopathic scoliosis.

Authors:  J Carrier; C E Aubin; I Villemure; H Labelle
Journal:  Med Biol Eng Comput       Date:  2004-07       Impact factor: 2.602

2.  Growth modulation in the management of growing spine deformities.

Authors:  Ibrahim Akel; Muharrem Yazici
Journal:  J Child Orthop       Date:  2008-11-20       Impact factor: 1.548

3.  Differential wedging of vertebral body and intervertebral disc in thoracic and lumbar spine in adolescent idiopathic scoliosis - A cross sectional study in 150 patients.

Authors:  Hitesh N Modi; Seung Woo Suh; Hae-Ryong Song; Jae-Hyuk Yang; Hak-Jun Kim; Chetna H Modi
Journal:  Scoliosis       Date:  2008-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.